A phase II study of alternating paclitaxel and carboplatin in patients with advanced ovarian cancer

被引：0
|
作者：
Adams, M
Mort, D
Coleman, R
Wiliams, L
Evans, A
Thompson, M
机构：
[1] VELINDRE HOSP NHS TRUST,CARDIFF,S GLAM,WALES
[2] WESTON PK HOSP TRUST,SHEFFIELD,S YORKSHIRE,ENGLAND
[3] BRISTOL MYERS SQUIBB,PHARMACEUT RES INST,HOUNSLOW,ENGLAND
来源：
EUROPEAN JOURNAL OF CANCER | 1995年 / 31A卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：496 / 496
页数：1
相关论文
共 50 条
  • [1] Phase I study of alternating doublets of topotecan/carboplatin and paclitaxel/carboplatin in patients with newly diagnosed, advanced ovarian cancer
    Gordon, AN
    Hancock, KC
    Matthews, CM
    Messing, M
    Stringer, CA
    Doherty, MG
    Teneriello, M
    GYNECOLOGIC ONCOLOGY, 2002, 85 (01) : 129 - 135
  • [2] Phase II study of the combination carboplatin and paclitaxel in patients with ovarian cancer
    Huinink, WWT
    vanWarmerdam, LJC
    Helmerhorst, TJ
    Schaefers, MCW
    Beijnen, JH
    Rodenhuis, S
    ANNALS OF ONCOLOGY, 1997, 8 (04) : 351 - 354
  • [3] Phase II study of paclitaxel and carboplatin in patients with advanced gastric cancer
    Gadgeel, SM
    Shields, AF
    Heilbrun, LK
    Labadidi, S
    Zalupski, M
    Chaplen, R
    Philip, PA
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (01): : 37 - 41
  • [4] A phase II study of sequential carboplatin, paclitaxel and topotecan in patients with previously untreated advanced ovarian cancer
    A E Guppy
    A E Nelstrop
    T Foster
    R Agarwal
    M J Seckl
    G J S Rustin
    British Journal of Cancer, 2004, 90 : 810 - 814
  • [5] A phase II study of sequential carboplatin, paclitaxel and topotecan in patients with previously untreated advanced ovarian cancer
    Guppy, AE
    Nelstrop, AE
    Foster, T
    Agarwal, R
    Seckl, MJ
    Rustin, GJS
    BRITISH JOURNAL OF CANCER, 2004, 90 (04) : 810 - 814
  • [6] A phase I/II study of carboplatin and paclitaxel in patients with epithelial ovarian cancer
    Yamamoto, R
    Minobe, S
    Kaneuchi, M
    Sakuragi, N
    Fujimoto, S
    Ishizaki, Y
    Domon, H
    Hareyama, H
    Sato, C
    Fujino, T
    Kawaguchi, I
    Yamaguchi, T
    Fujimoto, T
    Yoshiaki, K
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2002, 32 (04) : 128 - 134
  • [7] Phase II study of sequential doublets: topotecan and carboplatin, followed by paclitaxel and carboplatin, in patients with newly diagnosed advanced ovarian cancer
    Gordon, AN
    Asmar, L
    Messing, MJ
    Street, DG
    Pippitt, CH
    Bailey, CL
    Savage, J
    Young, JA
    GYNECOLOGIC ONCOLOGY, 2004, 94 (02) : 533 - 539
  • [8] A phase II study of sequential carboplatin, paclitaxel and topotecan in patients with previously untreated advanced ovarian cancer.
    Guppy, AE
    Nelstrop, A
    Agarwal, R
    Seckl, MJ
    Rustin, GJS
    BRITISH JOURNAL OF CANCER, 2002, 86 : S44 - S44
  • [9] A phase II study of carboplatin and paclitaxel in the treatment of patients with advanced esophageal and gastric cancer
    Philip, PA
    Zalupski, MM
    Gadgeel, S
    Hussain, M
    Shields, A
    SEMINARS IN ONCOLOGY, 1997, 24 (06) : S86 - S88
  • [10] Paclitaxel and carboplatin in pretreated advanced gastric cancer: A phase II study
    Stathopoulos, GP
    Rigatos, SK
    Fountzilas, G
    Polyzos, A
    Stathopoulos, JG
    ONCOLOGY REPORTS, 2002, 9 (01) : 89 - 92
12345